Atlas Trials

The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients

Clinical trial NCT00470808 · UNKNOWN

Trial details

NCT number
NCT00470808
Sponsor
HaEmek Medical Center, Israel
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Atherosclerosis
Start date
2007-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.